Trial
NCT03526185
A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
—
Condition
Metastatic Melanoma
Intervention
Tumor Infiltrating Lymphocytes
Why stopped
lack of funds
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-25